GLYCO-TARGETIERENDE THERAPEUTIKA

Patent europeic · EP3107563 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3107563
Numer da la dumonda
EP15744656
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
20-02-2015
Publitgà
28-12-2016
Concedì
07-04-2021
La protecziun finescha il pli tard
19-02-2035
Proxima taxa annuala scadenta
28-02-2027
Classas IPC
A61K 39/00 (2006.01)
A61K 38/28 (2006.01)
A61K 38/38 (2006.01)
A61K 39/35 (2006.01)
A61P 37/02 (2006.01)
A61P 37/06 (2006.01)
A61P 37/08 (2006.01)
A61K 47/54 (2017.01)
Prioritad
US 201461942942 P 21.02.2014
Dumonda PCT
PCT/IB2015/001145 20.02.2015
Publicaziun PCT
WO2015/140648 24.09.2015
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-03-2026

    Midada

    Published in Swissreg on 01.03.2026

  2. 01-03-2025

    Midada

    Published in Swissreg on 01.03.2025

  3. 01-03-2024

    Midada

    Published in Swissreg on 01.03.2024

  4. 06-03-2023

    Midada

    Published in Swissreg on 06.03.2023

  5. 16-02-2022

    Midada

    Published in Swissreg on 16.02.2022

  6. 10-06-2021

    Represchentant inscrit

    Representative
    TR-IP Consulting LLC, Route du Coutset 18, 1485 Nuvilly

    Published in Swissreg on 10.06.2021

  7. 07-04-2021

    Concedì

    Published in Swissreg on 07.04.2021

Partidas

Inventur

WILSON, David Scott

Chicago, IL 60601, US

LORENTZ, Kristen Marie

CH-1022 Chavannes-pres-Renens

KONTOS, Stephane

CH-1022 Chavannes-pres-Renens

GAI, Shuning

CH-1196 Gland

HUBBELL, Jeffrey A.

Chicago, IL 60615-1915, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.